ApoB vs LDL Cholesterol: What's the Difference and Which Should You Track?
You've heard Peter Attia or Andrew Huberman talk about apoB. Your doctor still measures LDL. Here's the honest comparison — what apoB tells you that LDL doesn't, when it actually matters, and what to do about it without becoming someone who optimizes everything.
The 60-second answer
Standard LDL cholesterol (LDL-C) measures the amount of cholesterol your LDL particles are carrying. ApoB measures the actual number of those particles, plus a few other atherogenic particles that LDL-C doesn't count. Each cholesterol particle has exactly one apoB protein on its surface, so apoB is a direct particle count.
Most of the time, LDL-C and apoB tell you the same story. Sometimes they don't. The "sometimes they don't" is the case for testing apoB. If they do agree, focus on the simpler test. If they disagree, apoB usually wins as the better predictor.
You don't have to test apoB to be doing the right things. You just have a slightly better picture if you do.
What apoB actually measures
ApoB stands for apolipoprotein B. It's a structural protein that sits on the outer surface of several different cholesterol particles:
- LDL (the well-known one)
- VLDL (very-low-density lipoprotein, carries triglycerides)
- IDL (intermediate-density, a transitional particle)
- Lp(a) (the inherited risk factor, covered in detail here)
Each of those particles contributes to atherosclerosis. Each one has exactly one apoB on its surface. So measuring apoB gives you a single number that captures all the atherogenic traffic in your blood.
Standard LDL-C measures only the cholesterol cargo inside LDL particles. It misses VLDL, IDL, and Lp(a) almost entirely. For most people, this doesn't matter — LDL is the dominant atherogenic particle and LDL-C is a fine proxy. For some people, it matters a lot.
The "discordance" problem
About 20–30% of adults have what's called LDL-apoB discordance — their LDL-C and apoB don't tell the same story.
The classic case: small dense LDL
Some people have many small, dense LDL particles instead of fewer larger ones. Each small particle carries less cholesterol, so the LDL-C number looks normal. But there are still a lot of particles, each one capable of embedding in artery walls. ApoB picks up the count; LDL-C misses it.
This pattern is common in metabolic syndrome (high triglycerides, low HDL, insulin resistance, abdominal weight). If your LDL-C is around 100 but you have those metabolic features, your apoB might be 110 or 120 — meaningfully elevated risk hidden behind a "normal" LDL.
The opposite case
Some people have fewer, larger LDL particles. LDL-C looks elevated but particle count (apoB) is more reasonable. This pattern is associated with somewhat lower risk than the LDL-C number alone would suggest, though "somewhat" is doing real work in that sentence — high LDL-C is still a problem even when particles are large.
Why some doctors switched to apoB
The case for apoB:
- Direct particle count — captures the actual mechanism of atherosclerosis (particle penetration into artery walls)
- Doesn't need fasting
- Better discrimination of risk in metabolic syndrome and diabetes
- Captures Lp(a) and VLDL automatically (you don't need separate tests)
- Cleaner relationship with cardiovascular outcomes in some studies
The case for sticking with LDL-C:
- Decades of guidelines, treatment thresholds, and risk calculators are built on LDL-C
- Universally available, cheap, on every standard panel
- For 70–80% of people, gives the same answer as apoB
- ApoB still requires extra ordering effort and isn't always covered
The 2026 ACC/AHA guidelines now mention apoB as a "useful additional measurement" but don't make it the default. That's the institutional balance — they acknowledge the evidence, but most clinics still order LDL-C as the standard test and add apoB selectively.
Peter Attia, longevity podcasts, and the apoB ceiling
If you've ended up in this corner of the internet, you've probably heard Peter Attia argue for very aggressive apoB targets — under 60 mg/dL, sometimes under 50, regardless of standard cholesterol categories.
His reasoning, simplified:
- Cardiovascular disease is the #1 killer in industrialized countries
- Lifetime exposure to atherogenic particles drives the disease
- The relationship is dose-dependent: lower apoB = lower lifetime risk, with no apparent floor in the data
- Therefore, lower apoB is better, and "normal" thresholds are too lenient
This is intellectually consistent and the data support it. It also leads to medication recommendations (often high-dose statins or PCSK9 inhibitors) that are more aggressive than current guidelines call for.
Our position at Hey Heart: the calm middle. Lower is genuinely better up to a point. Aggressive lowering does reduce events. But the marginal benefit of going from apoB 80 to apoB 50 is much smaller than going from 130 to 80, and chasing optimization can become a hobby that crowds out other important things in life. For most people without other major risk factors, getting apoB into the 70s or 80s is excellent. Going lower if you're high-risk and motivated is reasonable. Going lower because a podcast told you to is optional.
What apoB target is right for you
Loose, evidence-informed framing:
- Under 60 mg/dL — what high-risk patients (existing heart disease, very high Lp(a), familial hypercholesterolemia) often aim for
- 60–80 mg/dL — optimal range for most adults working actively on cardiovascular health
- 80–100 mg/dL — acceptable for most low-risk adults; what most general guidelines target
- 100–120 mg/dL — borderline elevated; lifestyle action recommended
- Above 120 mg/dL — elevated; medication often considered alongside lifestyle
Your doctor will weigh apoB against your other risk factors. The number alone doesn't dictate action — context does, just like with LDL.
How to lower apoB
The good news: almost everything that lowers LDL also lowers apoB. The interventions overlap heavily.
Reduce saturated fat
Lowers LDL and apoB roughly equally. The hidden sources are usually the issue.
Add soluble fiber and plant sterols
Both lower LDL particle count, which means lower apoB. Plant sterols can drop apoB by 6–10% on their own.
Reduce carbohydrate intake (especially refined)
This is where apoB and LDL-C can diverge. Lower carb intake reduces VLDL and small dense LDL more than it reduces LDL-C. So someone cutting refined carbs might see their apoB drop noticeably while LDL-C barely moves. This is a feature, not a bug — they're meaningfully reducing risk.
Lose visceral fat
Belly fat drives metabolic syndrome and small dense LDL. Losing 5–10% of body weight if you're carrying excess visceral fat reliably improves apoB.
Move
Exercise lowers triglycerides and VLDL, which reduces apoB more than it reduces LDL-C.
Statins (if needed)
Reduce LDL and apoB roughly proportionally. Both fall together.
Should you get an apoB test?
You probably should if any of these apply:
- You have metabolic syndrome features (high triglycerides, low HDL, abdominal weight)
- You're prediabetic or diabetic
- Your LDL looks "fine" but you have strong family history of early heart disease
- You're using cholesterol numbers to make a medication decision and you want a second opinion that LDL agrees with
- You're on a low-carb or keto diet and want to track risk more accurately than LDL-C alone (LMHR phenotype, see below)
You probably don't urgently need it if all of these apply:
- Your LDL is in a clearly normal range
- You have no metabolic syndrome features
- You have no family history of early heart disease
- Your Lp(a) (if tested) is normal
The "LMHR" question
People on ketogenic or carnivore diets sometimes develop very high LDL-C — the "lean mass hyper-responder" phenotype. The keto community argues these high LDL numbers don't matter because the particles are large and HDL is high.
ApoB testing is the cleanest way to evaluate this claim for an individual. If LDL-C is 250 but apoB is 80, the particles are indeed large and few — and that person's risk is somewhat elevated but not as catastrophic as LDL alone suggests. If apoB is also 150, the "large particles" theory doesn't apply and risk is genuinely high.
Our calm position: if you're on a keto/low-carb diet and your LDL is high, get apoB tested. Use the data, not the ideology, to decide what to do.
Frequently asked questions
What's a good apoB level?
Under 90 mg/dL is acceptable for most adults. Under 80 is optimal for active management. Under 60 is what high-risk patients often aim for. The relationship with risk is linear — lower is better, with no clear floor.
Is apoB covered by insurance?
Increasingly yes, especially since the 2026 guidelines mentioned it as useful. Out of pocket: $20–40 at most labs. Direct-to-consumer through Quest or Labcorp is similar.
How do I ask my doctor for an apoB test?
Just say: "Can we add apoB to my next lipid panel? I'd like a more complete picture." Most physicians will agree. If they push back, "metabolic syndrome features" or "family history of early CVD" usually unlocks it.
Does apoB need to be fasted?
No. Unlike triglycerides (which fluctuate with meals), apoB is stable across fed and fasted states. You can test it any time of day.
Can apoB be too low?
Theoretically yes, but in practice almost no one is ever in that range without medication. The lowest apoB in healthy hunter-gatherer populations is around 50, with no apparent harm. There's no current evidence that lowering apoB into the 30s or 40s with medication causes problems, though it's still being studied.
Why does my doctor not order apoB by default?
Inertia and guideline-following. Most US guidelines still anchor to LDL-C, so most doctors test what they can act on. This is changing slowly. You can usually move the conversation by asking for it.
Hey Heart helps you track the food side — saturated fat — that drives both LDL and apoB. Learn more →
Hey Heart is a wellness app and not a medical device. The information in this article is general guidance only and is not medical advice, diagnosis, or treatment. Always consult your doctor about your specific health situation.